← Scroll for more →
BridgeBio Oncology Therapeutics, Inc. (BBOT)
Pharmaceutical Preparations
Latest Price
$2.62
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
4.03
P/B Ratio
0.65
Institutional Ownership
73.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 17.88M | $136.0M | 22.32% | -- | 2026-06-30 |
| Deerfield Management Company, L.P. | 4.89M | $37.0M | 6.10% | -- | 2026-06-30 |
| Omega Fund Management, LLC | 3.29M | $25.0M | 4.11% | -- | 2026-06-30 |
| EcoR1 Capital, LLC | 2.82M | $21.0M | 3.52% | -- | 2026-06-30 |
| Alphabet Inc. | 2.82M | $21.0M | 3.52% | -- | 2026-06-30 |
| Wellington Management Group LLP | 2.79M | $21.0M | 3.48% | -29.0K | 2026-06-30 |
| Enavate Sciences GP, LLC | 2.63M | $20.0M | 3.28% | -- | 2026-06-30 |
| Citadel Advisors LLC | 2.62M | $19.0M | 3.27% | +89.1K | 2026-06-30 |
| Novo Holdings A/S | 2.25M | $17.0M | 2.81% | +64.1K | 2026-06-30 |
| BlackRock, Inc. | 2.15M | $16.0M | 2.69% | +65.7K | 2026-06-30 |